Recombinant Rat Prostaglandin E2 receptor EP2 subtype (Ptger2)

What is the Prostaglandin E2 receptor EP2 subtype (Ptger2)?

Prostaglandin E2 receptor EP2 subtype (Ptger2) is a G protein-coupled receptor that specifically binds prostaglandin E2 (PGE2). This receptor's activity is mediated by G(s) proteins that stimulate adenylate cyclase, leading to increased intracellular cAMP levels. The subsequent elevation in cAMP is responsible for various physiological effects, including smooth muscle relaxation . EP2 receptor has emerged as a crucial mediator of many physiological and pathological events, including inflammation, synaptic transmission, cognitive function, and tumor progression .

What are the primary signaling pathways associated with EP2 receptor activation?

The EP2 receptor activates multiple signaling pathways that contribute to its diverse biological functions:

• cAMP/PKA pathway: Upon PGE2 binding, EP2 activates Gs proteins, stimulating adenylate cyclase to increase intracellular cAMP. This activates protein kinase A (PKA), which can phosphorylate CREB, a transcription factor important for long-term potentiation (LTP) and memory formation .

• cAMP/Epac pathway: EP2 activation can signal through this pathway, particularly in chronic inflammation contexts .

• β-arrestin-dependent pathway: EP2 receptor can recruit β-arrestin 1 in a G protein-independent pathway that promotes tumor cell growth and migration. This occurs through phosphorylation of Src, which activates EGFR, leading to activation of PI3K/Akt and Ras/ERK pathways .

• βγ subunit-mediated signaling: The βγ subunits liberated upon Gsα activation can directly stimulate PI3K/Akt signaling, leading to phosphorylation and inactivation of GSK-3β, causing nuclear translocation of β-catenin to initiate growth-promoting gene expression .

How does EP2 receptor signaling differ from EP4 receptor signaling in rats?

While both EP2 and EP4 receptors are coupled to Gs proteins and increase cAMP levels, they exhibit important functional differences:

These differences indicate that EP2 has approximately 13-fold higher sensitivity to PGE2 compared to EP4, and selective agonists like CP-533,536 can effectively distinguish between these receptor subtypes in experimental settings .

What are the most effective methods for detecting EP2 receptor expression in rat tissues?

Several complementary approaches can be employed for robust detection of EP2 receptor expression:

• Immunohistochemistry (IHC): Use of specific antibodies such as rabbit monoclonal anti-Prostaglandin E Receptor EP2/PTGER2 (clone EPR8030(B)) which has been validated for rat samples. The protocol typically involves overnight incubation with primary antibody at 4°C, followed by rabbit secondary antibody (30 min), avidin–biotin complex conjugate (30 min), diaminobenzidine (5 min), and methyl-green counterstain .

• Western blotting: For quantitative assessment of EP2 protein levels in tissue homogenates, using validated antibodies such as EPR8030(B) .

• RT-PCR/qPCR: For measurement of Ptger2 mRNA expression levels.

• Flow cytometry: For detection of EP2 expression in isolated cells or cell suspensions using fluorescently labeled antibodies .

• Functional assays: Measuring cAMP accumulation in response to selective EP2 agonists can provide indirect evidence of receptor expression and activity .

How can recombinant rat EP2 receptor be effectively expressed in cell culture systems?

Though the search results don't provide a detailed protocol, Chinese hamster ovary (CHO-K1) cells have been successfully used to express functional rat EP2 receptors . Based on standard practices for recombinant receptor expression:

• Vector selection: Use mammalian expression vectors containing strong promoters (CMV, EF1α) for efficient expression.

• Transfection method: Lipid-based transfection reagents or electroporation can be effective for CHO-K1 cells.

• Selection strategy: Include antibiotic resistance markers (G418, hygromycin) for stable cell line generation.

• Functional validation: Confirm expression through cAMP accumulation assays using PGE2 or selective EP2 agonists such as CP-533,536 .

• Expression verification: Employ Western blotting or immunofluorescence with specific antibodies to confirm protein expression and localization.

What experimental models are most appropriate for studying EP2 receptor function in vivo?

Several experimental models have proven valuable for investigating EP2 receptor function:

• Genetic models: EP2 receptor knockout mice have provided insights into the physiological and pathological roles of EP2 signaling .

• Pharmacological models:

  • Rat urethral tissue models for studying EP2-mediated relaxation responses

  • Anesthetized rat models for measuring urethral perfusion pressure changes in response to EP2 agonists

• Disease models:

  • Collagen-induced arthritis (CIA) models to study EP2's role in joint inflammation

  • Inflammatory bowel disease (colitis) models to investigate intestinal inflammation

  • UV-induced acute skin inflammation models

  • Neuroinflammatory and neurodegenerative disease models

  • Cancer models, particularly colorectal cancer and neuroblastoma

How does EP2 receptor signaling contribute to neurological function and disorders?

EP2 receptor signaling exhibits a complex dual role in the central nervous system:

• Neuroprotective effects: In acute models of excitotoxicity, EP2 activation can provide neuroprotection via cAMP/PKA signaling pathways .

• Synaptic plasticity: EP2 receptors regulate synaptic transmission and cognitive function. EP2 receptor knockdown via RNA interference decreases long-term potentiation (LTP) in rat visual cortex. Upon theta-burst stimulation, Gs-coupled EP2 receptor translocates from cytosol to postsynaptic membrane, enhancing postsynaptic cAMP/PKA signaling, which activates CREB, a transcription factor crucial for LTP and memory formation .

• Neuroinflammation: Conversely, in chronic inflammatory conditions, EP2 activation can accentuate neuroinflammation through the cAMP/Epac pathway, potentially contributing to delayed neurotoxicity .

• Receptor trafficking: EP2 receptor trafficking mimics that of AMPA-type glutamate receptors during LTP expression, suggesting a coordinated mechanism for modulating synaptic strength .

What is the role of EP2 receptor signaling in cancer progression?

EP2 receptor signaling promotes cancer progression through multiple mechanisms:

• Tumor cell proliferation: EP2 activation initiates G protein-dependent and -independent signaling cascades that stimulate cell proliferation .

• β-arrestin-mediated pathways: Upon PGE2 stimulation, EP2 recruits β-arrestin 1 to phosphorylate Src, activating EGFR and downstream PI3K/Akt and Ras/ERK pathways, promoting tumor cell activities .

• GSK-3β/β-catenin signaling: The βγ subunits released upon Gsα activation can directly stimulate PI3K/Akt signaling, leading to phosphorylation and inactivation of GSK-3β, causing nuclear translocation of β-catenin to initiate growth-promoting gene expression in colorectal cancer .

• Cell migration: β-arrestin 1 also phosphorylates JNK, which upregulates Profilin-1 (Pfn-1), increasing F-actin expression and organization, thus promoting tumor cell migration .

• Clinical associations: PTGER2 overexpression in colorectal cancer is associated with specific molecular features, including MSI-high status . The PGE2/EP2 signaling pathway also contributes to neuroblastoma malignancy, suggesting it as a potential therapeutic target .

How does EP2 receptor signaling influence inflammatory processes?

EP2 receptor plays crucial roles in various inflammatory conditions:

• Th17 differentiation: PGE2 signaling through EP2 exacerbates inflammation by increasing IL-23 expression and reducing IL-12/IL-27, which together cause T cells to differentiate to Th17 effectors in inflammatory bowel disease and collagen-induced arthritis .

• Cytokine expression: PGE2, together with IL-1β and IL-23, facilitates Th17 cell differentiation and cytokine expression mainly through EP2 and cAMP signaling .

• Skin inflammation: PGE2 signaling via EP2 receptors regulates UV-induced acute skin inflammation by increasing skin microenvironmental blood flow .

• Anti-inflammatory therapies: Modulation of EP2 receptor signaling is emerging as a therapeutic alternative to non-steroidal anti-inflammatory drugs (NSAIDs) for treating cyclooxygenase-2 (COX-2)-governed pathological conditions .

What are the optimal conditions for studying EP2 receptor-mediated cAMP responses?

Effective measurement of EP2 receptor-mediated cAMP responses requires careful experimental design:

• Cell models: Chinese hamster ovary (CHO-K1) cells expressing rat EP2 receptors provide a clean system for studying receptor-specific responses .

• Agonist concentrations:

  • PGE2: Effective concentration range of 0.1-100 nM, with EC50 of approximately 1.3 nM for rat EP2

  • CP-533,536 (selective EP2 agonist): Effective range of 0.1-100 nM, with EC50 of approximately 3.0 nM

• Assay methods:

  • Direct measurement of cAMP accumulation in cell lysates or tissues

  • ELISA-based detection systems

  • Fluorescence-based live-cell reporters for real-time monitoring

• Data analysis: Concentration-response curves should be generated to determine EC50 values and maximum response magnitudes .

What selective EP2 receptor agonists and antagonists are available for rat studies?

The limited selection of selective EP2 tools underscores the need for careful experimental design:

CP-533,536 represents a valuable tool for studying EP2-specific effects, as it increases cAMP accumulation in cells expressing rat EP2 receptors but has no effect on cells expressing EP4 receptors even at high concentrations .

What is the role of EP2 receptors in smooth muscle function?

EP2 receptor activation produces important effects on smooth muscle:

• Urethral function: Both PGE2 and selective EP2 agonist CP-533,536 produce concentration-dependent relaxation and increase cAMP levels in rat urethral tissues. In anesthetized rats, these compounds dose-dependently decrease urethral perfusion pressure .

• Mechanism of action: The relaxant response of rat urethral tissue to PGE2 and CP-533,536 occurs via stimulation of EP2 receptors and appears to be mediated by cAMP-dependent mechanisms .

• Physiological significance: These findings suggest that EP2 receptor signaling plays an important role in urethral function and potentially in urinary tract physiology .

How should EP2 receptor expression be quantified in immunohistochemical studies?

Accurate quantification requires standardized methods:

• Expression scoring: In published studies, PTGER2 positivity has been defined as cytoplasmic overexpression in ≥50% of tumor cells compared to normal epithelial cells, which typically show weak cytoplasmic PTGER2 expression .

• Observer validation: For reliability, immunohistochemical markers should be interpreted by multiple investigators blinded to other data. Published concordance rates between observers for PTGER2 scoring are approximately 0.84 (κ=0.69), indicating substantial agreement .

• Validation approach: When no established cutoff exists, one approach is to use associated molecular features (such as MSI status) to determine a biologically relevant cutoff for positivity .

• Control tissues: Always include appropriate positive and negative controls, and compare expression to normal adjacent tissue .

What are the key considerations when developing recombinant rat EP2 receptor constructs?

When designing recombinant constructs:

• Sequence verification: Ensure the construct contains the complete coding sequence for rat Ptger2 without mutations.

• Epitope tagging: Consider adding epitope tags (His, FLAG, HA) to facilitate detection, but verify that tags do not interfere with receptor function.

• Signal peptide: Maintain the native signal peptide for proper membrane targeting.

• Fusion reporters: GFP or luciferase fusions may be useful for localization or functional studies but may alter receptor trafficking.

• Expression system compatibility: Optimize codon usage for the intended expression system.

• Functional validation: Always verify that the recombinant receptor maintains natural ligand binding and signaling properties .

How can researchers address contradictory findings regarding EP2 receptor function?

Given the complexity of EP2 signaling, apparent contradictions in research findings require careful consideration:

• Contextual differences: EP2 receptor can have opposing effects depending on acute versus chronic activation. In the brain, it mediates neuroprotection in acute excitotoxicity models but may contribute to neuroinflammation in chronic conditions .

• Signaling pathway divergence: Different experimental conditions may favor distinct signaling pathways (cAMP/PKA vs. cAMP/Epac vs. β-arrestin-dependent), leading to different functional outcomes .

• Tissue-specific effects: EP2 function may vary substantially between tissues due to differences in receptor density and the presence of various downstream effectors .

• Species differences: While there is conservation across species, subtle differences in EP2 structure and function may exist between rats, mice, and humans .

• Methodological considerations: Experiments using genetic ablation versus pharmacological approaches may yield different results due to compensatory mechanisms in knockout models .